|
| 36151879 | Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. | Ann Neurol | 2023 |
| 37755427 | Antiretroviral therapy intensification for HIV-associated neurocognitive disorder? | AIDS | 2023 |
| 37766242 | Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV. | Viruses | 2023 |
| 36477867 | Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. | Brain | 2023 |
| 36780493 | Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group. | PLoS One | 2023 |
| 36310512 | Higher Levels of Cerebrospinal Fluid and Plasma Neurofilament Light in Human Immunodeficiency Virus-Associated Distal Sensory Polyneuropathy. | Clin Infect Dis | 2023 |
| 35324536 | Post-acute sensory neurological sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: the COVID-PN observational cohort study. | Pain | 2022 |
| 35773234 | Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virus. | Brain | 2022 |
| 35405431 | The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells. | J Neuroimmunol | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 36348972 | Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Alzheimers Dement (Amst) | 2022 |
| 36283148 | Neurosarcoidosis: A call to arms. | J Neuroimmunol | 2022 |
| 36151869 | Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. | Ann Neurol | 2022 |
| 35157246 | Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. | J Neurovirol | 2022 |
| 35081558 | Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV. | J Acquir Immune Defic Syndr | 2022 |
| 35196927 | The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021. | Mult Scler | 2022 |
| 33417672 | Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. | Clin Infect Dis | 2021 |
| 33565583 | Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy. | Pain Med | 2021 |
| 33483734 | Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. | Clin Infect Dis | 2021 |
| 33746107 | IgG4-Related Disease of the Skull and Skull Base-A Systematic Review and Report of Two Cases. | World Neurosurg | 2021 |
| 34302776 | Hope for progressive multifocal leukoencephalopathy. | Lancet Neurol | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 34037724 | Imaging Synaptic Architecture in Human Immunodeficiency Virus: Checkpoint for Brain Function? | Clin Infect Dis | 2021 |
| 33981939 | Cohort study protocol to characterize the incidence and severity of neuropathic pain in patients with severe acute respiratory syndrome coronavirus 2 infection. | Pain Rep | 2021 |
| 33947785 | Large Mitochondrial DNA Deletions in HIV Sensory Neuropathy. | Neurology | 2021 |
| 33257476 | Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. | Neurology | 2021 |
| 33251716 | Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. | Arthritis Rheumatol | 2021 |
| 33251700 | Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. | Arthritis Care Res (Hoboken) | 2021 |
| 33029936 | Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrum. | Am J Med Genet A | 2021 |
| 31343069 | Thinking About Getting Older With Human Immunodeficiency Virus. | Clin Infect Dis | 2020 |
| 34589877 | Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV. | Brain Behav Immun Health | 2020 |
| 33461199 | Herpesvirus Infections and Risk of Parkinson's Disease. | Neurodegener Dis | 2020 |
| 33057367 | Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy. | PLoS One | 2020 |
| 32619341 | Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. | Ann Clin Transl Neurol | 2020 |
| 32644212 | Checkpoint therapy for progressive multifocal leukoencephalopathy: pointless? | Eur J Neurol | 2020 |
| 32202612 | Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. | JAMA Neurol | 2020 |
| 32166631 | Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration. | Neurotherapeutics | 2020 |
| 32484854 | Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. | Blood Adv | 2020 |
| 31576785 | Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities. | J Int Neuropsychol Soc | 2020 |
| 30291567 | White matter damage, neuroinflammation, and neuronal integrity in HAND. | J Neurovirol | 2019 |
| 30209774 | Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. | Mol Neurobiol | 2019 |
| 31208273 | High alert! | Mult Scler | 2019 |
| 31515289 | Dosing interval of natalizumab in MS: Do good things come to those who wait? | Neurology | 2019 |
| 31305261 | Is successful HIV therapy a Pyrrhic victory for the brain? | J Clin Invest | 2019 |
| 30870195 | Effects of comorbidity burden and age on brain integrity in HIV. | AIDS | 2019 |
| 30864100 | Progressive multifocal leukoencephalopathy treated with nivolumab. | J Neurovirol | 2019 |
| 30890191 | Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates. | J Int Neuropsychol Soc | 2019 |
| 30702516 | Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. | AIDS | 2019 |
| 28874213 | Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. | J Int Neuropsychol Soc | 2018 |
| 30105172 | Progressive multifocal leukoencephalopathy with extended natalizumab dosing. | Neurol Clin Pract | 2018 |